Previous Close | 37.28 |
1-Year Change | 22.23% |
6-Months Change | 23.12% |
3-Months Change | 13.07% |
Moving Avg (50d) | 32.612 |
Moving Avg (200d) | 32.737 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 318.4M |
Beta (3-Years) | 1.19 |
Revenue Growth (ttm) | 66.71% |
Net Profit Margin (ttm) | -13.05% |
Return On Assets (ttm) | -10.83% |
EPS (ttm) | -1 |
PE Ratio (ttm) | -37.28 |
Dividend Yield | % |
Asset Description: | Sanara MedTech Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-24 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
38.026 | 39.144 | 39.89 | 41.008 | 42.872 | 44.736 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.